Incidence and severity of adverse events from treatment with adjuvant trastuzamab-based chemotherapy in HER2+ breast cancer patients
Summary
Project ID: 2016-045/2018 0950 011 000
Type of Response: Research project
Knowledge User: Cancer Care Ontario
ICES Scientist: Craig Earle, Refik Saskin
Status: Completed
Information
Project ID
2016-045/2018 0950 011 000
Contributing ICES Scientists
Status
AHRQ Project
2025
Evaluate urethral drug-coated balloon (optilume) for recurrent bulbar urethral strictures in adult men
Project ID: 2025-001/ 2026 0950 196 000
Project Year: 2025
Knowledge User: Ontario Health
ICES Scientist: Luke Mondor
Type of Response: Research report or technical brief
Status: Completed
AHRQ Project
2025
Seniors eligible for OSDCP 2025
Project ID: 2025-027/2026 0950 151 001
Project Year: 2025
Knowledge User: Halton Region-Public Health Surveillance & Evaluation
ICES Scientist: Luke Mondor
Type of Response: Research report or technical brief
Status: In progress